The modified Atkins diet in children with Prader-Willi syndrome.

Diet Ketogenic Low-carbohydrate diet Obesity Pediatric obesity Prader-Willi syndrome

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
03 06 2020
Historique:
received: 26 11 2019
accepted: 18 05 2020
entrez: 5 6 2020
pubmed: 5 6 2020
medline: 22 6 2021
Statut: epublish

Résumé

Prader-Willi Syndrome (PWS) is the most common genetic cause of obesity. Various dietary strategies have been used for weight management for people with PWS. This was a clinical feasibility study to test the use of the Modified Atkins Diet (low carbohydrate and high fat) for children with PWS ages 6-12 years who were overweight/obese. Participants went on the Modified Atkins Diet for 4 months and then returned to have anthropometry repeated including repeat labs and behavior questionnaires. Seven children (ages 6-12) were enrolled in the study. Four participants completed the 4-month diet trial; two were unable to comply with the diet and stopped prematurely. One patient lost 2.9 kg; the others maintained their weight. Adverse effects were increases in LDL (expected based on larger studies) and hypercalciuria (with no renal stones) for one patient. Positive effects on hyperphagia and behavior were noted subjectively by families. The Modified Atkins Diet can be a feasible low carbohydrate option for children with Prader-Willi Syndrome for weight management. Long-term use of the diet in patients with Prader-Willi Syndrome needs to be studied further.

Sections du résumé

BACKGROUND
Prader-Willi Syndrome (PWS) is the most common genetic cause of obesity. Various dietary strategies have been used for weight management for people with PWS.
METHODS
This was a clinical feasibility study to test the use of the Modified Atkins Diet (low carbohydrate and high fat) for children with PWS ages 6-12 years who were overweight/obese. Participants went on the Modified Atkins Diet for 4 months and then returned to have anthropometry repeated including repeat labs and behavior questionnaires.
RESULTS
Seven children (ages 6-12) were enrolled in the study. Four participants completed the 4-month diet trial; two were unable to comply with the diet and stopped prematurely. One patient lost 2.9 kg; the others maintained their weight. Adverse effects were increases in LDL (expected based on larger studies) and hypercalciuria (with no renal stones) for one patient. Positive effects on hyperphagia and behavior were noted subjectively by families.
CONCLUSION
The Modified Atkins Diet can be a feasible low carbohydrate option for children with Prader-Willi Syndrome for weight management. Long-term use of the diet in patients with Prader-Willi Syndrome needs to be studied further.

Identifiants

pubmed: 32493369
doi: 10.1186/s13023-020-01412-w
pii: 10.1186/s13023-020-01412-w
pmc: PMC7268481
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

135

Références

N Engl J Med. 1977 Apr 7;296(14):774-9
pubmed: 840278
J Dev Behav Pediatr. 2008 Apr;29(2):129-34
pubmed: 18408535
Genes (Basel). 2019 Nov 06;10(11):
pubmed: 31698873
J Acad Nutr Diet. 2017 Aug;117(8):1279-1292
pubmed: 28754198
Expert Rev Mol Med. 2005 Jul 25;7(14):1-20
pubmed: 16038620
ScientificWorldJournal. 2009 Sep 14;9:934-9
pubmed: 19768349
J Am Diet Assoc. 1992 Jul;92(7):823-30, 833
pubmed: 1624651
Epilepsia. 2006 Feb;47(2):421-4
pubmed: 16499770
J Autism Dev Disord. 1987 Sep;17(3):365-74
pubmed: 3654488
Epilepsy Behav. 2018 Feb;79:82-86
pubmed: 29253679
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Nutr Rev. 1991 Aug;49(8):235-8
pubmed: 1956590
Pediatr Neurol. 2016 Mar;56:30-34
pubmed: 26774551
Epilepsia. 2008 Nov;49 Suppl 8:37-41
pubmed: 19049584
Nutr Neurosci. 2016;19(3):131-7
pubmed: 25383724

Auteurs

Grace Felix (G)

Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Pediatric Specialists of Virginia/INOVA Children's Hospital, Fairfax, Virginia, USA.

Eric Kossoff (E)

Department of Pediatric Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Bobbie Barron (B)

Institute of Clinical and Translational Research, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Caitlin Krekel (C)

Institute of Clinical and Translational Research, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Elizabeth Getzoff Testa (EG)

Department of Psychology, Center for Pediatric Weight Management & Healthy Living, Mt. Washington Pediatric Hospital, Baltimore, MD, USA.

Ann Scheimann (A)

Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins School of Medicine, Baltimore, MD, USA. ascheima@jhmi.edu.
Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins Hospital, 600 N. Wolfe Street Brady 320, Baltimore, MD, 21287-2631, USA. ascheima@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH